Skip to main navigation
AADI Bioscience AADI Bioscience AADI Bioscience
Navigation
Primary Navigation
  • Company
    • The Company
    • Leadership
    • Board of Directors
  • Our Science
    • mTOR Pathway
    • TSC1 & TSC2
    • nab Technology Platform
    • Publications and Abstracts
  • Our Medicine
    • Our Medicine
    • Advanced Malignant PEComa
    • Expanded Access
  • Pipeline
  • Patients
    • Patient Advocacy
    • Clinical Trials
  • Investors & News
  • Contact Us
    • General Contact
    • For Healthcare Professionals
    • Careers

SEC Filing Details

Secondary Nav Investors & News
  • IR Overview
  • Stock
    • Stock Quote & Chart
    • Analyst Coverage
  • Press Releases
  • Event Calendar
  • Presentations
    • Corporate Presentations
    • Scientific Presentations
  • Financial
    • SEC Filings
    • Financial Reports
    • Quarterly Results
    • Forms
  • Governance
    • Governance Highlights
    • Committee Composition
  • IR Resources
    • Investor FAQ
    • Information Request
    • Email Alerts
    • IR Contacts

Document Details

Form
SC 13G/A
Filing Date
02/14/23
Document Date
02/14/23
Form Description
An amendment to the SC 13G filing
Filing Group
Other
Company
Aadi Bioscience, Inc.
Issuer
AADI BIOSCIENCE, INC.

Filing Formats

View HTML
Download PDF
Download DOC
Download XLS

Toolkit

  • Print Page
  • RSS Feeds
  • Email Alerts
  • IR Contacts
 logo

17383 Sunset Blvd, Suite A250
Pacific Palisades, CA 90272

Footer Links - Top
  • Home
  • Leadership
  • Pipeline
  • Patients
  • Contact
  • Careers
Footer Links - Bottom
  • LinkedIn
  • Twitter
  • Terms & Conditions
  • Privacy